Updates in Eosinophilic Esophagitis: Exploring Underlying Mechanisms and Integrating Novel Targeted Therapy to Improve Patient Care
Presented by: PeerView for Sanofi and Regeneron Alliance
Date/time: Friday, October 14, 6:00 pm - 7:30 pm
Room: Sebastian L 3/4
Description: Eosinophilic esophagitis (EoE) is an increasingly prevalent, chronic, T2 inflammatory disease triggered by food and/or environmental allergens. Due to underlying tissue inflammation, patients suffer diminished quality of life due to symptoms such as weight loss, difficulty swallowing, and heartburn. Patients can experience these symptoms for a long time before receiving a proper diagnosis. Once diagnosed, treatment options have historically been limited. Fortunately, therapies that treat other type 2 disorders are in development or are approved to treat EoE. In this one-hour interactive activity using patient cases and consultation, participants will benefit from expert instruction in the art of diagnosis (especially identifying comorbid T2 disorders such as asthma), the underlying causes, and the newest treatments for EoE, including biologic therapies. Through peer coaching, participants will learn how to integrate these newer therapies into management plans to ease symptoms and manage the disease.
Chair & Presenter:
Sandeep K. Gupta, MD
Community Health Network
Riley Hospital for Children
Indiana University School of Medicine
Indianapolis, Indiana
Presenter:
Gregory M. Constantine, MD
Clinician-Scientist - Eosinophilic Disorders
Allergy/Immunology
Bethesda, Maryland
Presenter:
Amanda B. Muir, MD
The Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania
Registration link:
www.PeerView.com/EoEOrlando22-Live